Lycia Therapeutics Funding: $232M Raised, Series D (2025)
Lycia Therapeutics is a Biotech company based in South San Francisco, CA. It has raised $232M in total funding. Latest round: Series D.
Lycia Therapeutics funding overview
Lycia Therapeutics is a Biotech company based in South San Francisco, CA. Lycia Therapeutics has raised $232M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2025. The round record for Lycia Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Venrock Healthcare Capital Partners, Janus Henderson Investors, Marshall Wace, Franklin Templeton, Redmile Group, RTW Investments and 4 others. 10 distinct backers are named across the disclosed rounds.
Lycia Therapeutics at a glance
Total raised
$232M
Latest round
Series D
Latest round date
July 2025
Industry
Biotech
Headquarters
South San Francisco, CA
Notable investors
Venrock Healthcare Capital Partners, Janus Henderson Investors, Marshall Wace, Franklin Templeton, Redmile Group, RTW Investments, Blue Owl Healthcare Opportunities, Invus
Frequently asked about Lycia Therapeutics funding
How much has Lycia Therapeutics raised?
Lycia Therapeutics has raised $232M in total disclosed funding across the rounds on record.
Who has invested in Lycia Therapeutics?
Venrock Healthcare Capital Partners, Janus Henderson Investors, Marshall Wace, Franklin Templeton, Redmile Group, RTW Investments are named among the investors backing Lycia Therapeutics.
What was the latest Lycia Therapeutics funding round?
The most recent disclosed round is a Series D, announced in July 2025.
Where is Lycia Therapeutics based?
Lycia Therapeutics is based in South San Francisco, CA.
What sector does Lycia Therapeutics operate in?
Lycia Therapeutics is tracked under Biotech from South San Francisco, CA, with $232M in disclosed funding.
When did Lycia Therapeutics last raise?
The last disclosed Lycia Therapeutics round closed in July 2025 at Series D.
We update the Lycia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in South San Francisco and their backers are listed below.
